July 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for July 2020. This roundup includes...
Online CME Improves Knowledge of Emerging Treatments for Anemia
According to Amy Larkin, PharmD, CHCP, and colleague as the treatment of anemia in patients with chronic kidney disease (CKD) continues to improve with...
Pooled Analysis of Roxadustat for Anemia in Non–Dialysis-Dependent CKD Patients
In phase 3 studies examining the efficacy of roxadustat for the treatment of anemia in patients with chronic kidney disease (CKD), the therapy improved...
Risk of Red Blood Cell Transfusion Lowered with Roxadustat in Patients with CKD Anemia
Patients requiring red blood cell transfusions may experience reactions leading to allo-sensitization, or rarely transmit infections; thus, treatments that reduce the need for transfusion...
Multidisciplinary Team Model Improves Anemia Management in Peritoneal Dialysis Patients
Management of anemia in patients receiving peritoneal dialysis carries more challenges compared with anemia management in patients receiving hemodialysis. Peritoneal dialysis patients are seen...
Long-acting Anemia Treatment May Stabilize Hemoglobin Levels
There are few scientific-based data comparing clinical outcomes of erythropoiesis-stimulating agents (ESAs) in patients on dialysis. Roberta Lugo-Robles, MPH, and colleagues in Puerto Rico...
Worsened Outcomes Associated with Anemia in CKD
Anemia is a common comorbidity in patients with chronic kidney disease (CKD); however, there are few data available on the long-term clinical burden of...
